Cambridge Investment Research Advisors
QGEN icon

Cambridge Investment Research Advisors’s Qiagen QGEN Stock Holding History

Cambridge Investment Research Advisors’s Portfolio QGEN Stock Details QGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-16,013
Closed -$708K – 3407
2024
Q1 		$708K Buy
+16,013
New +$730K ﹤0.01% 1981

Other funds holding QGEN

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
NI
Nuance Investments Kansas City, Missouri $717M AUM 3.8% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
DZ Bank
DZ Bank Frankfurt Am Main, Germany $113B AUM 36.92% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Cambridge Investment Research Advisors's QGEN Position: Q2 2024 in Review

Cambridge Investment Research Advisors sold out of Qiagen (QGEN) in Q2 2024, closing a stake of 16,013 shares — an estimated $708K sold.

Cambridge Investment Research Advisors first reported a position in QGEN in Q1 2024 and held it in 1 quarter. The position peaked at $708K in Q1 2024. 305 funds tracked by Wall St. Rank hold QGEN as of Q2 2024.

  • Cambridge Investment Research Advisors reported no remaining Qiagen position as of Q2 2024 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 16,013 Qiagen shares in Q2 2024, an estimated $708K.
  • Cambridge Investment Research Advisors first reported a position in Qiagen in Q1 2024 and held it in 1 quarter.
  • Cambridge Investment Research Advisors's Qiagen position peaked at $708K in Q1 2024.
  • 305 funds tracked by Wall St. Rank held Qiagen as of Q2 2024.

Based on Cambridge Investment Research Advisors's 13F filing for Q2 2024, filed 26 Jul 2024.